Literature DB >> 8655654

Does the Wilms' tumour suppressor gene, WT1, play roles in both splicing and transcription?

J P Charlieu1, S Larsson, K Miyagawa, V van Heyningen, N D Hastie.   

Abstract

The Wilms' tumour suppressor gene (WT1) encodes a protein(s) with 4 zinc fingers that is essential for the development of the genitourinary system. A considerable body of evidence exists to support the idea that WT1 binds DNA and functions as a transcription factor. However, we have shown recently by confocal microscopy and immunoprecipitation studies that a significant proportion of WT1 is associated with splice factors in kidney cell lines, fetal tissues and transfected Cos cells. Different isoforms of WT1 are produced by an alternative splice that leads to the presence or absence of a 3 amino acid insertion (KTS) between zinc fingers 3 and 4. We have shown that these different forms localise differently in the nucleus. The +KTS form mainly localises with splice factors, the -KTS form mainly with transcription factors. Here we propose a model to account for these different localisations. Also, we discuss the possible significance of these findings.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8655654     DOI: 10.1242/jcs.1995.supplement_19.14

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  7 in total

1.  Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein.

Authors:  J H Laity; H J Dyson; P E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Wilms Tumor Suppressor, WT1, Cooperates with MicroRNA-26a and MicroRNA-101 to Suppress Translation of the Polycomb Protein, EZH2, in Mesenchymal Stem Cells.

Authors:  Murielle M Akpa; Diana Iglesias; LeeLee Chu; Antonin Thiébaut; Ida Jentoft; Leah Hammond; Elena Torban; Paul R Goodyer
Journal:  J Biol Chem       Date:  2015-12-10       Impact factor: 5.157

3.  WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues.

Authors:  Justin Crawford; Christina Raykha; Daevina Charles; Bing Siang Gan; David B O'Gorman
Journal:  J Cell Commun Signal       Date:  2015-06-30       Impact factor: 5.782

4.  Human and mouse MOK2 proteins are associated with nuclear ribonucleoprotein components and bind specifically to RNA and DNA through their zinc finger domains.

Authors:  V Arranz; F Harper; Y Florentin; E Puvion; M Kress; M Ernoult-Lange
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

5.  Evidence from a mouse model that epithelial cell migration and mesenchymal-epithelial transition contribute to rapid restoration of uterine tissue integrity during menstruation.

Authors:  Fiona L Cousins; Alison Murray; Arantza Esnal; Douglas A Gibson; Hilary O D Critchley; Philippa T K Saunders
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

6.  A novel CDX2 isoform regulates alternative splicing.

Authors:  Matthew E Witek; Adam E Snook; Jieru E Lin; Erik S Blomain; Bo Xiang; Michael S Magee; Michael Magee; Scott A Waldman
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

7.  Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).

Authors:  Aminetou Mint Mohamed; Marie Balsat; Morgan Thenoz; Catherine Koering; Lea Payen-Gay; Meyling Cheok; Hussein Mortada; Didier Auboeuf; Christiane Pinatel; Mohamed El-Hamri; Charles Dumontet; Emeline Cros; Pascale Flandrin-Gresta; Olivier Nibourel; Claude Preudhomme; Mauricette Michallet; Xavier Thomas; Franck Nicolini; Françoise Solly; Denis Guyotat; Lydia Campos; Eric Wattel; Franck Mortreux
Journal:  Oncotarget       Date:  2016-01-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.